Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 2/2012

01-02-2012 | Rhinology

Association of PPAR polymorphisms with cytokine levels in allergic rhinitis

Authors: Magdolna Krasznai, Kinga Szaniszlo, Helga Kraxner, Eszter Vargha, Margit Kovacs, Edit Kaszas, Gyorgyi Mezei, Endre Cserhati, Zoltan Borocz, Karoly Cseh

Published in: European Archives of Oto-Rhino-Laryngology | Issue 2/2012

Login to get access

Abstract

Our aim was to study the association of Pro12Ala and exon6 C161T polymorphisms of PPARgamma and intron7 G/C polymorphisms of PPAR-alpha with clinical symptoms, peak nasal inspiratory flow values, serum soluble TNF-alpha, TNF-R1, Fas, Fas ligand and IgE concentrations in patients with seasonal allergic rhinitis during and after pollen season. We performed a follow-up study of 66 Hungarian patients with seasonal allergic rhinitis and 180 healthy referent subjects. We used PCR-RFLP technique and ELISA. The distribution of mutant alleles of PPAR-gamma and -alpha did not differ in patients and referent subjects. Patients carrying the mutant 12Ala, exon6 161T alleles of PPAR-gamma and intron7 C allele of PPAR-alpha had significantly higher clinical symptom score values, TNF-alpha and IgE levels and lower peak nasal inspiratory flow values during and after pollen season. The results indicated that nuclear receptors PPAR-gamma and PPAR-alpha are involved in the regulation of inflammatory mediator production in patients with seasonal allergic rhinitis and polymorphisms of the receptors are very likely to contribute to the heterogeneity of clinical and immunological parameters of allergic patients.
Literature
1.
go back to reference Strauss DS, Glas CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551–558CrossRef Strauss DS, Glas CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551–558CrossRef
2.
go back to reference Shah YM, Morimura K, Gonzalez FJ (2007) Expression of peroxisome proliferator-activated receptor-gamma in macrophages supresses experimentally induced colitis. Am J Physiol 292:657–666 Shah YM, Morimura K, Gonzalez FJ (2007) Expression of peroxisome proliferator-activated receptor-gamma in macrophages supresses experimentally induced colitis. Am J Physiol 292:657–666
3.
go back to reference Adachi M, Kurotani R, Morimura K et al (2006) Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55:1104–1113PubMedCrossRef Adachi M, Kurotani R, Morimura K et al (2006) Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55:1104–1113PubMedCrossRef
4.
go back to reference Kobayashi M, Thomassen MJ, Rambasek T et al (2005) An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model. Ann Allegry Asthma Immunol 95:468–473CrossRef Kobayashi M, Thomassen MJ, Rambasek T et al (2005) An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model. Ann Allegry Asthma Immunol 95:468–473CrossRef
5.
go back to reference Ueki S, Matsuwaki Y, Kayaba H, Oyamada A et al (2004) Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 134(suppl 1):30–36PubMedCrossRef Ueki S, Matsuwaki Y, Kayaba H, Oyamada A et al (2004) Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 134(suppl 1):30–36PubMedCrossRef
6.
go back to reference Woerly G, Honda K, Loyens M et al (2003) Peroxisome proliferator-activated receptor alpha and gamma downregulate allergic inflammation and eosinophil activation. J Exp Med 198:411–421PubMedCrossRef Woerly G, Honda K, Loyens M et al (2003) Peroxisome proliferator-activated receptor alpha and gamma downregulate allergic inflammation and eosinophil activation. J Exp Med 198:411–421PubMedCrossRef
7.
go back to reference Cardell LO, Hägge M, Uddman R et al (2005) Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis. Respir Res 6:1–8CrossRef Cardell LO, Hägge M, Uddman R et al (2005) Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis. Respir Res 6:1–8CrossRef
8.
go back to reference Palmer CN, Doney AS, Ismail T et al (2007) PPARG locus haplotype variation and exacerbations in asthma. Clin Pharmacol Ther 81:713–718PubMedCrossRef Palmer CN, Doney AS, Ismail T et al (2007) PPARG locus haplotype variation and exacerbations in asthma. Clin Pharmacol Ther 81:713–718PubMedCrossRef
9.
go back to reference Brown JL, Behndig AF, Sekerel BE et al (2007) Lower airways inflammation in allergic rhinitis: comparison with asthmatics and normal controls. Clin Exp Allergy 37:688–695PubMedCrossRef Brown JL, Behndig AF, Sekerel BE et al (2007) Lower airways inflammation in allergic rhinitis: comparison with asthmatics and normal controls. Clin Exp Allergy 37:688–695PubMedCrossRef
10.
go back to reference Riccio AM, Tosca MA, Cosentino C et al (2002) Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy 32:422–426PubMedCrossRef Riccio AM, Tosca MA, Cosentino C et al (2002) Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy 32:422–426PubMedCrossRef
11.
go back to reference Kinikli G, Ateş A, Turgay M et al (2006) Serum-soluble Fas antigene level in patients with allergic rhinitis: its relation to specific immunotherapy. Allergy Asthma Proc 27:145–147PubMed Kinikli G, Ateş A, Turgay M et al (2006) Serum-soluble Fas antigene level in patients with allergic rhinitis: its relation to specific immunotherapy. Allergy Asthma Proc 27:145–147PubMed
12.
go back to reference Kato M, Nosaki Y, Yoshimoto T et al (1999) Different serum soluble Fas levels in patients with allergic rhinitis and bronchial asthma. Allergy 54:1299–1302PubMedCrossRef Kato M, Nosaki Y, Yoshimoto T et al (1999) Different serum soluble Fas levels in patients with allergic rhinitis and bronchial asthma. Allergy 54:1299–1302PubMedCrossRef
13.
go back to reference Zakrzewska A, Gryczyńska D, Kobos J et al (2006) Expression of Fas ligand and CTLA4 in adenoids as a predictive value for allergic rhinitis development in children. Int Arch Allergy Immunol 140:223–230PubMedCrossRef Zakrzewska A, Gryczyńska D, Kobos J et al (2006) Expression of Fas ligand and CTLA4 in adenoids as a predictive value for allergic rhinitis development in children. Int Arch Allergy Immunol 140:223–230PubMedCrossRef
14.
go back to reference Chuang LM, Hsiung CA, Chen YD et al (2001) Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. J Mol Med 79:656–664PubMedCrossRef Chuang LM, Hsiung CA, Chen YD et al (2001) Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. J Mol Med 79:656–664PubMedCrossRef
15.
go back to reference Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease. Cardiovascular Research 44:588–594PubMedCrossRef Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease. Cardiovascular Research 44:588–594PubMedCrossRef
16.
go back to reference Flavell DM, Jamshidi Y, Hawe E et al (2002) Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 105:1440–1445PubMedCrossRef Flavell DM, Jamshidi Y, Hawe E et al (2002) Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 105:1440–1445PubMedCrossRef
17.
go back to reference Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287PubMedCrossRef Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287PubMedCrossRef
18.
go back to reference Pascual G, Fong AL, Ogawa S et al (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437:759–763PubMedCrossRef Pascual G, Fong AL, Ogawa S et al (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437:759–763PubMedCrossRef
19.
go back to reference Remels AH, Langen RC, Gosker HR et al (2009) PPAR gamma inhibits NF kappa B dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 297:174–183CrossRef Remels AH, Langen RC, Gosker HR et al (2009) PPAR gamma inhibits NF kappa B dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 297:174–183CrossRef
20.
go back to reference Asada K, Sasaki S, Suda T et al (2004) Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 169:195–200PubMedCrossRef Asada K, Sasaki S, Suda T et al (2004) Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 169:195–200PubMedCrossRef
21.
go back to reference Belvisi MG, Hele DJ (2008) Peroxisome proliferators-activated receptor as novel targets in lung disease. Chest 134:152–157PubMedCrossRef Belvisi MG, Hele DJ (2008) Peroxisome proliferators-activated receptor as novel targets in lung disease. Chest 134:152–157PubMedCrossRef
Metadata
Title
Association of PPAR polymorphisms with cytokine levels in allergic rhinitis
Authors
Magdolna Krasznai
Kinga Szaniszlo
Helga Kraxner
Eszter Vargha
Margit Kovacs
Edit Kaszas
Gyorgyi Mezei
Endre Cserhati
Zoltan Borocz
Karoly Cseh
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 2/2012
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-011-1710-z

Other articles of this Issue 2/2012

European Archives of Oto-Rhino-Laryngology 2/2012 Go to the issue